COA / COA-2026-0211
CJC-1295 no DAC / Ipamorelin 5/5 mg
Lot COA-2026-0211
99.77% (3-vial average)HPLC
Report date
2026-09-03
Testing lab
AV Analytics
Appearance
Lyophilized
| Analyte | Method | Result |
|---|---|---|
| Purity | UPLC-UV + UPLC-MS | 99.77% (3-vial average) |
| Identity | UPLC-UV + UPLC-MS | Conforms (UPLC-MS ionization profile match) |
| Net peptide content | UPLC-UV + UPLC-MS | Vial 1 CJC 5.61 / IPA 5.97 · Vial 2 CJC 5.36 / IPA 5.19 · Vial 3 CJC 4.96 / IPA 4.91 mg |
| Endotoxin | LAL, USP <85> | Pass (rFC, <0.5 EU/mL; vials 0.13/0.09/0.07) |
Independent analysis by AV Analytics. Results apply to the stated lot. For laboratory and research use only — not for human or animal consumption.




